Research is being conducted on the role of GLP-1s in breast cancer treatment, with some studies suggesting a potential link to weight loss and reduced risk of cancer recurrence. The relationship between GLP-1s, obesity, and cancer risk is also being explored. Findings on the safety, timing, and effectiveness of GLP-1s in breast cancer recovery are being reported, but the details and implications of these findings are not entirely clear.